A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma.

Autor: Horvilleur E; Medical Research Council Toxicology Unit, Leicester, UK., Sbarrato T; Medical Research Council Toxicology Unit, Leicester, UK., Hill K; Medical Research Council Toxicology Unit, Leicester, UK., Spriggs RV; Medical Research Council Toxicology Unit, Leicester, UK., Screen M; Medical Research Council Toxicology Unit, Leicester, UK., Goodrem PJ; Medical Research Council Toxicology Unit, Leicester, UK., Sawicka K; Medical Research Council Toxicology Unit, Leicester, UK., Chaplin LC; Medical Research Council Toxicology Unit, Leicester, UK., Touriol C; INSERM UMR 1037-CRCT-Equipe 5 CHU Rangueil Toulouse, France., Packham G; Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK., Potter KN; Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK., Dirnhofer S; Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland., Tzankov A; Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland., Dyer MJ; Medical Research Council Toxicology Unit, Leicester, UK., Bushell M; Medical Research Council Toxicology Unit, Leicester, UK., MacFarlane M; Medical Research Council Toxicology Unit, Leicester, UK., Willis AE; Medical Research Council Toxicology Unit, Leicester, UK.

Publikováno v: Leukemia [Leukemia] 2014 May; Vol. 28 (5), pp. 1092-102. Date of Electronic Publication: 2013 Oct 18.